.Attributes Medication, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point of view requires incorporation of individuals along with MASLD as well as dimension of liver outcomes in cardio-- renal-- metabolic trials, when data suggest mechanistically probable benefits and also scientific security-- as well as summarizes factors to consider for test style and governing commendation.